Search

everythinglearnresearchcommunity

for

Search:↓

Intramuscular triamcinolone and pulse therapy with oral predonine are effective for alopecia areata with manageable side effects, but better relapse prevention is needed.

The LGBT-focused curriculum improved dermatology residents' confidence in treating LGBT patients.

Atopic dermatitis needs personalized treatment using various therapies, starting with topical corticosteroids.

The microneedle patches effectively treat allergic conjunctivitis with controlled, sustained release of medication.

Magnetized saline water may reduce chronic itching in elderly people.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

Topical corticosteroids may be a safe and effective treatment for severe alopecia areata in children.

DPCP treatment for alopecia areata can sometimes cause vitiligo.

TRP channels in the skin are important for sensation and health, and targeting them could help treat skin disorders.

SHISA6 helps maintain certain stem cells in mouse testes by blocking signals that would otherwise cause them to differentiate.

Vitamin D3 affects cell differentiation in specific skin areas.

Higher androstenedione levels in women with PCOS are linked to more severe symptoms.

Somatostatin may help protect hair follicles from immune attacks.

Researchers created a model to understand heart aging, highlighting the role of microRNAs and identifying key genes and pathways involved.

Women with PCOS had higher SRAGE levels, possibly linked to BMI, not PCOS.

Bupropion SR may help treat trichotillomania.

A new topical treatment for hair loss shows promise by targeting androgen receptors.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

Venusia CeraPlus cream and lotion effectively reduce eczema severity and improve skin moisture.

For sensitive scalp, treatment is personalized and may include specific medications and hydration, while avoiding stress and irritating products.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

The combination of oral PUVA and corticosteroids helps regrow hair in severe alopecia areata.

OnabotulinumtoxinA treatment improved hair-pulling disorder and hair regrowth in a woman with chronic migraines.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Some treatments, like corticosteroids and sensitizing agents, can help with alopecia areata, but more high-quality research is needed.

Long-term Imiquimod treatment causes initial skin inflammation that lessens over time, and topical corticosteroids reduce this inflammation and cytokines in a mouse model of psoriasis.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

imTA and pulse therapy are effective for alopecia areata with manageable side effects, but relapse rates need improvement.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

Targeted photodynamic therapy is a promising method for precise disease treatment and diagnosis.